Samsrita Labs Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Samsrita Labs Ltd. from all sources in a single place.

Load latest

Samsrita Labs Ltd.

14 Jun 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Outcome of Board Meeting

BSE India

With reference to the subject cited, this is to inform the Exchange that at the Board meeting of M/s. Dr Habeebullah Life Sciences Limited held on Friday, the 14th day of June, 2019 at 3.30 p.m. at the registered office of the Company situated at Survey No 36, 2-5-36/CLRD/1, Chintalmet X Roads, Upperpally, Attapur, Rajendra Nagar Mandal, Hyderabad, Telangana, 500048 the following were duly considered and approved by the Board: 1. Allotment of 10,00,000 Equity Shares upon conversion of warrants issued to the Promoters. 2. Reviewed and updated various policies on company website as per SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 The meeting of the Board of Directors commenced at 3.30 P.M (IST) and concluded at 4.30 P.M (IST)

pdf

Samsrita Labs Ltd.

07 Jun 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Board Meeting Intimation for Conversion Of Warrants Into …

BSE India

Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/06/2019 ,inter alia, to consider and approve With reference to the subject cited, this is to inform the Exchanges that meeting of the Board of Directors of M/s.Dr Habeebullah Life Sciences Limited will be held on Friday, the 14th day of June, 2019, at 3.30 p.m. at the Registered Office of the Company to consider and approve the following Businesses; 1. Conversion of Warrants into Equity Shares - Promoters. 2. Any other business with the permission of chair. This is for the information and records of the Exchange, please.

pdf

Samsrita Labs Ltd.

07 Jun 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Closure of Trading Window

BSE India

We hereby inform that in terms of Company's' Code of Conduct for Prevention of Insider Trading, the Trading window for dealing in securities of the Company will remain closed for all the insiders from Saturday, 8th June, 2019 to Sunday, June 16, 2019 (both days inclusive) for the purpose of Conversion of Warrants into equity shares in Board meeting scheduled to be held on Friday, 14th June, 2019 at 3.30 PM at the Registered Office of the Company.

pdf

Samsrita Labs Ltd.

01 Jun 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) …

BSE India

Based on the certificate received from M/s. Venture Capital & Corporate Investments Private Limited, Registrar and Transfer Agent Of the Company, we hereby certify that the securities received for dematerialization have been mutilated and cancelled after due verification and the name of the depository has been substituted In our records as the registered owner within the stipulated time of receipt of the certificate of security. Further, we hereby certify that the securities which were dematerialized are listed on the Stock Exchange where the earlier issued securities are listed. This is for the information and records of the Exchange, please.

pdf

Samsrita Labs Ltd.

28 May 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Audited Financial Results For The Quarter And Year …

BSE India

1. Audited financial Statements (Standalone & Consolidated) for the quarter and year ended 31.03.2019. 2. The Auditor's Report on audited financial statements (Standalone & Consolidated) for the quarter and year ended 31.03.2019.

pdf

Samsrita Labs Ltd.

28 May 2019

22.05

5.00%

Annual Report

Annual report for Dr. Habeebullah Life Sciences Ltd. for FY-2019

pdf

Samsrita Labs Ltd.

20 May 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Board Meeting Intimation for Declaration Of Audited Financial …

BSE India

Dr Habeebullah Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve 1.The audited financial statement (standalone & consolidated) for quarter and year ended on March 31, 2019. 2.The auditor's report on audited financial statement (standalone & consolidated). 3.Any other business with the permission of the Chair.

pdf

Samsrita Labs Ltd.

16 May 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Reg.24(A)-Annual Secretarial Compliance

BSE India

Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report14/05/2019 3 Name of the Certifying Firm S.S.Reddy & Associates 4 Name of the Certifying Individual S.Sarveswar Reddy 5Membership TypeACS 6 Membership Number 12611 7 CP No. 7478 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO

pdf

Samsrita Labs Ltd.

30 Apr 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Format of Initial Disclosure to be made by …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayDr Habeebullah Life Sciences Ltd 2CININE579N01018 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 1 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Pooja Jain Designation: Company Secretary & Compliance officer EmailId: pcproductsindia@gmail.com Name of the Chief Financial Officer: KALIDINDI NIRUSHA Designation: Chief Financial Officer EmailId: info@drhlsl.com Date: 30/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Samsrita Labs Ltd.

29 Apr 2019

22.05

5.00%

Corp. Note

Dr Habeebullah Life Sciences Ltd - 539267 - Circular Of SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November, 2018 Fund …

BSE India

With reference to above SEBI circular of 26th November, 2018 in respect of fund raising by issuance of debt securities by Large Corporates (LC) and disclosure and compliance thereof by such large corporate. In this connection, we submit that our company Dr Habeebullah Life Sciences Limited is not coming under the Large Corporate (LC) category as per the framework provided in the aforesaid circular.

pdf

Is Dr. Habeebullah Life Sciences Ltd. worth buying?

5 Votes:

Buy 80.0%

Hold 20.0%

31.86% Fall from 52W High

High volume+gain today

Samsrita Labs Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Samsrita Labs Ltd. from all sources in a single place.